C07C 311/08
Having the nitrogen atom of at least one of the sulfonamide groups
Official title: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
C07C311/08 (Having the nitrogen atom of at least one of the sulfonamide groups) appears on 556 US grants and 574 published applications in this corpus.
Search patents in C07C- Granted patents
- 556
- Published applications
- 574
- Assignees
- 300
- Inventors
- 2,243
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 12 | 0 |
| 1993 | 8 | 0 |
| 1994 | 9 | 0 |
| 1995 | 11 | 0 |
| 1996 | 10 | 0 |
| 1997 | 14 | 0 |
| 1998 | 18 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 14 | 3 |
| 2002 | 14 | 14 |
| 2003 | 17 | 28 |
| 2004 | 11 | 41 |
| 2005 | 10 | 28 |
| 2006 | 18 | 44 |
| 2007 | 23 | 38 |
| 2008 | 23 | 27 |
| 2009 | 26 | 34 |
| 2010 | 34 | 40 |
| 2011 | 23 | 27 |
| 2012 | 27 | 20 |
| 2013 | 17 | 21 |
| 2014 | 25 | 30 |
| 2015 | 17 | 27 |
| 2016 | 17 | 23 |
| 2017 | 20 | 18 |
| 2018 | 13 | 13 |
| 2019 | 13 | 16 |
| 2020 | 13 | 15 |
| 2021 | 10 | 10 |
| 2022 | 7 | 11 |
| 2023 | 5 | 9 |
| 2024 | 6 | 19 |
| 2025 | 8 | 11 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Herbicidal tetrazole compounds25 Aug 2026US 12,715,849 B2Syngenta Crop Protection AG
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Inhibitors of phospholipid synthesis and methods of use3 Feb 2026US 12,540,115 B2The Board of Trustees of the Leland Stanford Junior University
- GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases6 Jan 2026US 12,516,016 B2Eubulus Biotherapeutics (Hong Kong) Limited
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Process for the preparation of a pde4 inhibitor11 Jun 2026US 2026/0159483 A1Chiesi Farmaceutici S.P. A.
- C7-fluoro substituted tetracycline compounds23 Apr 2026US 2026/0109665 A1Tetraphase Pharmaceuticals, Inc.
Most cited
By later US patents
- 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2206US 5,604,260 AMerck Frosst Canada, Inc. · 1997
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Aryl and heteroaryl compounds, compositions and methods of use99US 7,501,538 B2TransTech Pharma, Inc. · 2009